Article Text

Download PDFPDF
‘Fighting a Global War Using a Local Strategy’: contextualism in COVID-19 response in Africa
  1. Chinwe Lucia Ochu1,
  2. Oluwatosin Wuraola Akande1,2,
  3. Oyeronke Oyebanji3,
  4. Olaolu Aderinola4,
  5. Oladipo Ogunbode1,
  6. Rhoda Atteh5,
  7. Tochi Okwor1,
  8. Emeka Oguanuo1,
  9. Tijesu Ojumu1,
  10. Chinenye Ofoegbunam5,
  11. Blessing Ebhodaghe1,
  12. Gbenga Joseph4,
  13. Priscilla Ibekwe6,
  14. Chikwe Ihekweazu6
  1. 1Prevention, Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria
  2. 2Epidemiology and Community Health, University of Ilorin Teaching Hospital, Ilorin, Kwara, Nigeria
  3. 3Vaccine Research and Development, Coalition for Epidemic Preparedness Innovations, London, UK
  4. 4Health Emergency Preparedness and Response, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria
  5. 5Surveillance and Epidemiology, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria
  6. 6Office of the Director General, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria
  1. Correspondence to Dr Oluwatosin Wuraola Akande, Prevention, Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, 240102, Federal Capital Territory, Nigeria; akande.wuraola{at}gmail.com

Abstract

With a considerably high level of poverty, high population density and relatively fragile health systems, most African countries have a predominance of factors that could contribute to the rapid spread of the COVID-19 pandemic. Despite these challenges, the continent has shown capacity in its response to the pandemic. This may be related to the continent’s experience in responding to several infectious disease outbreaks such as Ebola disease, Lassa fever and cholera. Since the beginning of the COVID-19 pandemic, several local innovations have been developed and implemented. These innovations take into consideration unique circumstances in countries such as multiple government levels, belief in traditional medicine, limited access to medical supplies and others. This paper describes the various strategies developed in African countries across leadership and coordination, surveillance, laboratory capacity, case management, infection, prevention and control, risk communications, points of entry, research, logistics and supply chain, partnership, food security and education. We highlight the impact of these strategies on the response so far, and lessons that other regions across the world can learn from Africa’s response to COVID-19. Finally, we recommend the urgent need for increased investment in African health and social institutions to enable the development of African-owned and led strategies in response to disease outbreaks.

  • COVID-19
  • global health
  • public health

Data availability statement

Data sharing not applicable as no data sets were generated and/or analysed for this study. This is a narrative review, no data sets were generated.

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data sharing not applicable as no data sets were generated and/or analysed for this study. This is a narrative review, no data sets were generated.

View Full Text

Footnotes

  • Twitter @chinwe_Ochu, @tokwor7

  • Contributors All authors made significant contributions to this manuscript. Conceptualisation: CLO. First draft: OWA. Supervision: CLO and CI. Review and approval of final draft: all authors.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Provenance and peer review Not commissioned; externally peer reviewed.